Popular on EntSun
- Still Using Ice? FrostSkin Reinvents Hydration - 210
- Ice Melts. Infrastructure Fails. What Happens to Clean Water? - 190
- Author, Philanthropist Ethel Gardner Joins Creators' Rights Movement Advisory Board - 188
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy - 180
- François Arnaud, star of Heated Rivalry, is the real-life inspiration behind Christopher Stoddard's novel At Night Only - 162
- Cold. Clean. Anywhere. Meet FrostSkin - 158
- From "Law & Order" to the Lens: Matthew Bennett Photography Redefines the Professional Portrait in Downtown Toronto - 157
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships - 140
- Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida - 140
- The Legal AI Showdown: Westlaw, Lexis, ChatGPT… or EvenSteven? - 134
Similar on EntSun
- Nieuwe standaard in webdesign: Professionele website laten maken voor het MKB vanaf €249 door Websitepioniers
- $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
- Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
- Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
- K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
- Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
- Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
- The Franchise King® Releases Free Guide for Nervous Buyers
New Journal Article on the Challenges and Management of Sarcoidosis Supported by Foundation for Sarcoidosis Research
EntSun News/10900296
CHICAGO, Sept. 15, 2021 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is excited to share that a new article focused on sarcoidosis has been published by the New England Journal of Medicine (NEJM), the most influential authority in the field of medicine This article, Challenges of Sarcoidosis and Its Management, was written by two of FSR's Scientific Board Advisory (SAB) members, Elliott Crouser, MD, Ohio State University (Chair of the FSR SAB) and Marjolein Drent, MD, PhD, St. Antonius Hospital.
Sarcoidosis is a rare inflammatory multi-system disease. As a rare disease, sarcoidosis is not well-understood and often overlooked. This article details the risk factors associated with the development of sarcoidosis, highlighting the increased risk for African American's and women. Additionally, this foundational article explores the different clinical and diagnostic features and understanding of the clinical presentation of the disease and provides guidance for more timely and accurate diagnosis. Finally, this review provides a deeper understanding of the clinical presentation, understanding of prognosis, and pathways to better disease management for those living with sarcoidosis.
More on EntSun News
"Delayed diagnosis and lack of understanding of sarcoidosis are significant barriers to care for those living with sarcoidosis," says Mary McGowan, CEO for the Foundation for Sarcoidosis Research. "This article will be instrumental in providing all health care providers a deeper understanding of how to best diagnosis and treat this disease resulting in better patient outcomes."
Challenges of Sarcoidosis and Its Management is the first sarcoidosis scientific article published in NEJM since 2007 and is now considered the new standard of sarcoidosis review. To read the full report, visit https://www.nejm.org/doi/full/10.1056/NEJMra2101555?rss=searchAndBrowse
To learn more about FSR's research in sarcoidosis, please visit www.stopsarcoidosis.org.
About Sarcoidosis
Sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas—tiny clumps of inflammatory cells — in one or more organs of the body. Despite increasing advances in research, sarcoidosis remains difficult to diagnose with limited treatment options and no known cure.
More on EntSun News
About the Foundation for Sarcoidosis Research (FSR)
Established in 2000, The Foundation for Sarcoidosis Research (FSR) is the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients. Since inception, FSR has fostered over $5 million in sarcoidosis-specific research efforts and has worked diligently to provide resources to thousands. For more information and to join our community, visit www.stopsarcoidosis.org.
Media Contact
Cathi Davis
312-341-0500 ext 106
[email protected]
SOURCE Foundation for Sarcoidosis Research
Related Links
https://www.stopsarcoidosis.org/
Sarcoidosis is a rare inflammatory multi-system disease. As a rare disease, sarcoidosis is not well-understood and often overlooked. This article details the risk factors associated with the development of sarcoidosis, highlighting the increased risk for African American's and women. Additionally, this foundational article explores the different clinical and diagnostic features and understanding of the clinical presentation of the disease and provides guidance for more timely and accurate diagnosis. Finally, this review provides a deeper understanding of the clinical presentation, understanding of prognosis, and pathways to better disease management for those living with sarcoidosis.
More on EntSun News
- Melzi Job Coach Launches on iOS and Android: A Privacy-First AI Career Engine Built for Execution
- "The Mystery of Emma Thorn" Earns Nomination & Official Selection of the New Media Film Festival
- Jason's Big Climb Fundraiser - March 28, 2026
- Attention Singers & Musicians: Are you Looking for your Next Big Song Hits? Meet the Motherlode!
- Kling 3.0 Is Here: The AI Video Revolution You Can Actually Use Today
"Delayed diagnosis and lack of understanding of sarcoidosis are significant barriers to care for those living with sarcoidosis," says Mary McGowan, CEO for the Foundation for Sarcoidosis Research. "This article will be instrumental in providing all health care providers a deeper understanding of how to best diagnosis and treat this disease resulting in better patient outcomes."
Challenges of Sarcoidosis and Its Management is the first sarcoidosis scientific article published in NEJM since 2007 and is now considered the new standard of sarcoidosis review. To read the full report, visit https://www.nejm.org/doi/full/10.1056/NEJMra2101555?rss=searchAndBrowse
To learn more about FSR's research in sarcoidosis, please visit www.stopsarcoidosis.org.
About Sarcoidosis
Sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas—tiny clumps of inflammatory cells — in one or more organs of the body. Despite increasing advances in research, sarcoidosis remains difficult to diagnose with limited treatment options and no known cure.
More on EntSun News
- Dayton Fashion Week™ and Fashion Week of Cincinnati™ Open Designer Invitation Requests for 2027
- Fashion Sourcing I Leading B2B Marketplace For Custom Apparel Manufacturer in China
- DJ Drewstyle Announces March 2026 Performance Schedule at Estelle Scottsdale
- Detroit Hip-hop Takes Center Stage: Historic Official Sxsw Showcase Spotlights The City's Rising Music Economy
- Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
About the Foundation for Sarcoidosis Research (FSR)
Established in 2000, The Foundation for Sarcoidosis Research (FSR) is the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients. Since inception, FSR has fostered over $5 million in sarcoidosis-specific research efforts and has worked diligently to provide resources to thousands. For more information and to join our community, visit www.stopsarcoidosis.org.
Media Contact
Cathi Davis
312-341-0500 ext 106
[email protected]
SOURCE Foundation for Sarcoidosis Research
Related Links
https://www.stopsarcoidosis.org/
Filed Under: Business
0 Comments
Latest on EntSun News
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
- Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
- VanDyke Entertainment Inks Distribution Agreement with Warner Music Group's ADA
- Bay Street Yard to host St. Patrick's Day festivities
- RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
- Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival
- Grads aren't getting hired — here's what we're doing about it
- Tickets Now on Sale at TAP for the 2026 Season
- Brother Marcus Brings 2 Decades of Radio Excellence to New Podcast "The Elements of Inspiration"
- K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
- #WeAreGreekWarriors Comes to Detroit in Celebration of Women's History Month
- ZEELOOL Unveils ZEELOOL Healing Blooms: Spring's Nature-Inspired Eyewear
- Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
- Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
- The Franchise King® Releases Free Guide for Nervous Buyers
- Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
- CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
- NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
- Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth